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Aims: Researchers found a wide range of therapeutic properties in Spirulina sp. including as anti-cholesterol or anti-
hyperlipidemic agent. In this study, the lipid levels of domestic F. catus were induced in order to scrutinize the anti-
hyperlipidemic effects of local S. platensis LUQS1 strain, specifically at concentrations of 0.5 g/day and 1.0 g/day. 
Methodology and results: Elevation of serum lipid levels viz. total cholesterol (TC), high density lipoprotein (HDL), low 
density lipoprotein (LDL) and triglycerides (TG) as well as the status of kidney [creatinine (Cr) and blood urea nitrogen 
(BUN)] were observed in four groups of F. catus for 45 days. The highest levels for TC, LDL and TG (P<0.05) were 
recorded in high cholesterol diet group (CD) at day 45 with 291.67±2.87 mg·dL-1, 111.60±9.73 mg·dL-1 and 
146.33±10.44 mg·dL-1, respectively. HDL levels in Spirulina-treated groups (CA and CAA) were better than 
normolipidemic group (control, SD group), of which the maximum levels were displayed at day 30 specifically 
72.87±6.08 mg·dL-1 by cats-fed with high cholesterol diet treated with 0.5 g/day S. platensis LUQS1 (CA group). There 
were insignificant differences (P>0.05) in the BUN levels; however, the Cr levels in CAA group (day 30 and 45) were 
slightly out of normal range but did not classify under chronic condition.  
Conclusion, significance and impact of the study: Alternative treatments on hyperlipidemic cats were rarely reported 
by researchers and medicinal practitioners. Thus, the findings of this present study provided a genuine knowledge 
concerning the lipid-lowering effect of S. platensis LUQS1 on the hyperlipidemic cats. 
 




Awareness on hyperlipidemia, obesity and hypertension in 
human are greatly given by researchers around the world. 
Indeed, they have overlooked a few of isolated reports on 
animals owing to the fact that it is infrequent for animals to 
develop heart disease related to hyperlipidemia or 
hypolipidemia like human. As a matter of fact, animals are 
commonly linked to serious or even fatal ailments such as 
obesity, vision, pancreatitis and neurologic problems 
(Kline, 2005; Remillard, 2005; Steiner and Williams, 2005; 
Tucci-Prosěk, 2005). 
Spirulina sp. is formerly huddled under blue-green 
algae, however, due to its prokaryotic structure, it now 
belongs to cyanobacteria. It is enriched with proteins and 
vital nutrients, of which 18 essential amino acids (out of 
22) are available within Spirulina. This cyanobacterium is 
also completed with β-carotene, making it a perfect 
antioxidant (El-Sabagh et al., 2014), anti-inflammatory 
(Muhammad Nazrul et al., 2014), anti-cholesterol (Kim 
and Kim, 2005), anti-pyretic (Muhammad Nazrul et al., 
2014), antibacterial (Ozdemir et al., 2004) and also anti-
cancer (Konícková et al., 2014) agent. 
The first clinical trial of Spirulina sp. as an anti-
hyperlipidemic agent was done on albino rats (Devi and 
Venkataranam, 1983). Since then, bigger models have 
constructively been used for lipid-related studies including 
on human (Nakaya et al., 1988), rabbits (Colla et al., 
2008; Cheong et al., 2010) and pigs (Saeid et al., 2013). 
Information on cats is restricted due to their resistance 
capabilities towards cardiovascular diseases (CVDs) 
mostly atherosclerosis (Xiangdong et al., 2011). Cats are 
among animals with a null or low level of plasma 
cholesteryl ester transfer protein (CETP) and have 
naturally higher HDL particles in their bodies (Guyard-
Dangremont et al., 1998). Nonetheless, cats are the great 
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choice for primary and secondary hyperlipidemic disorders 
study (Kenneth, 2011). These animals have been 
accounted for several manifestations of lipid-related 
disorders such as diabetes mellitus, idiopathic 
hyperlipidemia, pancreatitis, nephrotic disorder, 
cholesterol ester stockpiling malady (Mosallanejad et al., 
2016) and lipid aqueous (Kluger et al., 2009; Xenoulis and 
Steiner, 2010). To date, no single animal models could 
utterly represent human atherosclerosis; albeit, there are 
two common cats’ features that relate to human, 
particularly the mechanical endothelial injury and 
cholesterol feeding behaviour (Xiangdong et al., 2011). 
A potential role of Spirulina sp. in lowering the 
cholesterol levels either in animal or human is totally 
lacking and remains unclear. Generally, Spirulina sp. will 
bind with cholesterol metabolites bile acids in the liver and 
later, reduce the cholesterol solubility (Deng and Chow, 
2010). In this investigation, priority was given to the 
beneficial effect of S. platensis LUQS1 with highlights on 
hyperlipidemic F. catus and the profile of Cr and BUN in 
signifying the cats’ kidney status. 
 
MATERIALS AND METHODS 
 
Source of S. platensis and maintenance 
 
The strain of S. platensis LUQS1 was isolated in Tasik 
Dayang Bunting, Langkawi, Kedah, Malaysia and 
maintained in modified Zarrouk medium (Zarrouk, 1966) at 
ambient temperature of 30±2 °C, alkaline pH (8.5 to 9.0) 
and under cool white fluorescent source (30 µmol photon 
m-2s-2).  
 
Animals, cholesterol and Spirulina diets 
 
Twelve healthy male of F. catus cats (size range: 2800-
3161 g) were assigned into four experimental groups; 
standard commercial diet (SD), high cholesterol diet (CD), 
cholesterol with 0.5 g/day S. platensis LUQS1 diet (CA) 
and cholesterol with 1.0 g/ day S. platensis LUQS1 diet 
(CAA). A total of 9% cholesterol per body weight was 
added into the daily diet of CD, CA and CAA groups. The 
cholesterol preparation was done by adding the 
chloroform and dried in a fume hood, prior to mixing 
process in 100 g intact pellet. These 3 groups were fed 
with high cholesterol diet for 2 weeks and after that 
continued with normal commercial diet. The total 
treatment duration was 45 days and free water access ad 
libitum was provided throughout the experimental period. 
Concentrated S. platensis LUQS1 was given to the cats 
daily via oral-gavage procedure. 
 
Protein and lipid composition in animal Feed  
 
Protein and lipid contents were determined accordingly to 






One millilitre (mL) of blood was drawn from a cephalic 
vein using a needle with the size of 23 G (Terumo, 
Japan). Blood was collected at day 0 (pre-treatment), 15, 
30 and 45 (post-treatment). Samples were centrifuged at 
5000 rpm for 10 min, prior to serum lipids evaluation (TC, 
LDL, TG and HDL) plus basic test of kidney-function (Cr 
and BUN). All samples were analyzed via automatic 
analyzer Roche Cobas Mira (Thermo Fisher Scientific, 
United State of America) and Hitachi 902 Machine 
(Hitachi, Japan).  
 
Statistical analysis  
 
Statistical differences between treatment and control 
groups were analyzed via ANOVA SPSS version 22 
(SPSS Statistics, IBM Corporation) and significance was 
accepted at P<0.05. All data were expressed as 
mean±standard deviation and levels of significance were 




The guidelines on handling the experimental animals were 
in compliance with the standard operational procedure of 
animal ethics which were verified by Animal Ethics 
Committee (Faculty of Veterinary Medicine) in Universiti 
Malaysia Kelantan. 
 




Table 1.0 presents the diet compositions for all 
investigated groups and Table 2.0 displays the body 
weight differences for F. catus throughout 45 experimental 
days. According to the results of the final weights, it can 
be concluded that all diets managed to increase the cats’ 
body weights. Yet, the highest daily weight gain (P<0.05) 
was recorded by CAA group (14.60±0.22 g/day) followed 
by CA (9.98±0.84 g/day), SD (9.78±1.20 g/day) and CD 
(5.77±0.45 g/day) group. The total protein (33.10±0.07%) 
and lipid (4.20±0.05%) contents in CAA group diet have 
significantly assisted the cats in increasing their body 
weights. Besides, the S. platensis LUQS1 
supplementation which is generally known for its high 
protein, lipid and carbohydrate, has also contributed to the 
weight gain. As observed, the daily weight gain in CAA 
group (1.0 g/day) group has denoted 46% higher than the 
CA group (0.5 g/day). Comparing to the standard diet or 
normal group (SD), the CAA group increased to about 
49% while the CD group stated a 41% reduction. Only the 
CD group demonstrated lower daily weight gain compared 
to others (CA and CAA groups) despite being supplied 
with the same cholesterol percentage (9% per body 
weight) in the diets. The daily weight gain between SD 
and CA groups displayed insignificant difference albeit 
their diet compositions (protein and lipid) were significantly 
different.  
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Protein, carbohydrate and fat notoriously contribute in 
weight gaining either in human or animal. These elements 
consist of the distinguishable value of calories, 
approximately 4 calories per gram deposited by protein 
and carbohydrate and about 9 calories per gram by fat.  
 





SD CD CA CAA 
















*SD: standard commercial diet group; CD: cholesterol diet group; 
CA: cholesterol with S. platensis LUQS1 (0.5 g/day) diet group; 
CAA: cholesterol with S. platensis LUQS1 (1 g/day) diet group; 
Values (mean ±standard deviation) with different superscripts in 
the same row were significantly different at the 5% level 
 





Initial weight (g) Final weight (g) Daily weight 
gain (g/day) 
SD 2870.67±47.11 3310.67±7.11 9.78±1.20b 
CD 2988.33±5.56 3248.00±26.00 5.77±0.45a 
CA 3139.33±14.44 3588.33±23.56 9.98±0.84b 
CAA 2967.00±4.67 3624.00±11.33 14.60±0.22c 
*Values (mean ±SD) with different superscripts in the same 
column were significantly different at the 5% level. 
 
The supplementation of S. platensis LUQS1 resulted in a 
greater live weight and also daily weight gain of F.catus. 
These outcomes were in agreement with Nagaoka et al. 
(2005), Colla et al. (2008), Heidarpour et al. (2011) and 
El-Sabagh et al. (2014) who have tested the effects of 
Spirulina sp. on rats, rabbits, calves and lambs, 
respectively. A complete set of nutrients in Spirulina sp. 
such as amino acids, vitamins, essential fatty acid, 
minerals and other nutrients, has possibly stimulated the 
gut microflora to exude extracellular enzymes that 
indirectly induced the growth of animals (Tovar-Ramírez 
et al., 2002; Gershwin and Belay, 2008). It is also worth to 
mention a report by Azabji-Kenfack et al. (2011) that the 
supplementation of S. platensis towards a group of 
emaciated HIV-infected adults in Africa has successfully 
gained 4.8 kg of their average weight. In human, essential 
amino acids are pivotal for anabolism and muscle mass 
reconstitution. According to Deng and Swanson (2015), 
the gut of canine and feline are similar to human’s gut 
especially their faecal microbial phylogeny and functional 
capacity. These similarities include the functional groups 
related to protein, metabolism of vitamins, carbohydrate, 
DNA and other major capacities. 
Status of kidney 
The nitrogenous end products of metabolism in human 
and animal are urea and creatinine. Thus far both 
elements are the most appropriate markers for renal 
(kidney) damage detection. Table 3.0 denotes the 
average levels of BUN and Cr in F. catus throughout the 
study period. The normal ranges of BUN and Cr levels 
obtained from the SD group were 44.33-65.33 mg·dL-1 
and 1.60-1.83 mg·dL-1, respectively. By referring to the 
BUN, all levels in the tested groups were within the normal 
ranges. As for Cr, at day 30 and 45, the levels in CAA 
group were slightly out of normal ranges albeit not 
categorized under chronic condition. The Cr levels for 
both days were 1.93±0.11 mg·dL-1 (day 30) and 2.13±0.04 
mg·dL-1 (day 45). 
A normal cat has about 0.2-0.5 g·L-1 (20-50 mg·dL-1) 
serum urea and 6-19 mg·L-1 (0.6-1.9 mg·dL-1) serum Cr 
(Chetboul et al. 2003). According to our recent results, 
only the serum Cr was in agreement with the 
aforementioned outcomes. Deguchi and Akuzawa (1997) 
have reported that the average levels of BUN and Cr in 
cats with chronic renal damage were 136.7 mg/100 mL 
and 5.09 mg/100 mL, respectively. To obtain a more 
precise result, it is recommended to measure the quantity 
of glomerular filtration, the quantity of urine excreted and 
also the tubular re-absorption rate (Deguchi and Akuzawa, 
1997). 
 
Serum lipids of F. catus 
 
Table 4.0 discloses the overall results for serum lipids in 
F. catus. For TC, significant differences (P<0.05) between 
the control group (SD) and CD, CA and CAA groups were 
detected at day 15, 30 and 45. At the end of the 
experimental period, CD group gave the highest TC levels 
compared to others. Meanwhile, the CAA group displayed 
the lowest TC level. Comparing to the control group (SD) 
at day 45, the increase of TC levels in CD group was by 
94% while the TC levels in Spirulina supplemented groups 
have reduced by 60% (CA group) and 64% (CAA group). 
In regard to LDL levels, there was a drastic increase 
recorded at day 30 in CD group of which the level hit up 
from 24.37±3.58 to 71.87±2.58 mg·dL-1. The level was 
gradually increased at day 45 with 111.60±9.73 mg·dL-1 
(P<0.05) that representing the highest LDL levels in this 
experiment. Almost the same scenario was also observed 
in TG levels. The cholesterol intake has forced the CD 
group to attain the highest TG levels at day 30 with 
190.97±2.64 mg·dL-1 (P<0.05). The LDL and TG levels for 
both treated groups (CA and CAA) were slightly similar to 
the control group (SD).  
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Table 3.0: Values of blood urea nitrogen (BUN) and creatinine (Cr) in the cats on day 0, 15, 30 and 45 of experimental 
period. 
Kidney’s enzymes (mg·dL-1)/ Treatment group Day 0 Time (Day) Day 15 Day 30 Day 45 
BUN     
SD 58.27±2.18a 65.33±3.78a 53.73±3.16ab 44.33±2.22a 
CD 62.73±2.49a 57.33±5.56a 65.53±5.02b 52.67±4.22a 
CA 64.00±2.00a 64.00±4.67a 56.87±6.09b 43.00±3.33a 
CAA 62.33±3.11a 64.83±1.22a 39.00±1.33a 44.67±7.56a 
Creatinine     
SD 1.60±0.13a 1.67±0.04b 1.83±0.44bc 1.8±0.07a 
CD 1.70±0.07a 1.60±0.07b 1.47±0.04a 1.83±0.04a 
CA 1.70±0.07a 1.13±0.04a 1.60±0.07ab 1.83±0.04a 
CAA 1.60±0.07a 1.80±0.07b 1.93±0.11c 2.13±0.04b 
*Values (mean ±SD) with different superscripts in the same column were significantly different at the 5% level. 
 
 
Table 4.0: Values of total cholesterol (TC), low density lipoprotein (LDL), triglyceride (TG) and high-density lipoprotein 
(HDL) in the cats throughout the experimental period. 
 
Concentration of serum lipids (mg·dL-1)/Treatment group 0 Time (Day) 15 30 45 
Total cholesterol (TC)     
SD 153.93±0.76a 150.20±2.27a 164.07±2.76a 150.03±6.04a 
CD 153.73±2.31a 188.37±1.82b 271.33±1.56b 291.67±2.87b 
CA 149.33±4.22a 91.37±1.58c 63.57±1.71c 59.43±3.91c 
CAA 144.67±2.44a 86.17±2.11c 48.90±4.60d 53.63±3.76c 
Low density lipoprotein (LDL)     
SD 15.20±0.80a 39.93±1.91a 20.40±3.60a 28.70±6.27a 
CD 15.60±1.73a 24.37±3.58b 71.87±2.58b 111.60±9.73b 
CA 22.57±2.38b 22.40±3.07b 18.53±3.69a 44.3±5.13a 
CAA 16.13±2.09ab 24.50±4.33b 22.30±2.87a 35.60±4.40a 
Triglyceride (TG)     
SD 41.60±2.13a 64.90±4.60a 52.27±5.51a 62.33±8.89a 
CD 62.57±2.38c 72.37±4.24a 190.97±2.64b 146.33±10.44b 
CA 42.53±2.36a 60.30±3.53a 62.53±3.38a 67.33±3.56a 
CAA 51.70±2.20b 60.83±5.22a 64.60±5.73a 65.40±6.93a 
High density lipoprotein (HDL)     
SD 43.80±1.87a 45.27±4.84a 43.40±6.93ab 38.37±6.911ab 
CD 46.67±1.78a 37.10±5.40a 28.53±6.36a 25.60±4.40a 
CA 46.67±2.89a 47.73±5.82a 72.87±6.08c 61.63±3.76c 
CAA 41.20±1.47a 44.22±4.22a 60.67±5.56bc 57.67±7.78bc 
*Values (mean ±SD) with different superscripts in the same column were significantly different at the 5% level. 
 
 
Table 5.0: Effect of S. platensis on weight performance, serum lipids and kidney in different animal models 
supplemented with S. platensis. 
 
Animal Dose of S. 
platensis 
Duration Effect of S. platensis on weight performance, serum lipids and 
kidney 
References 
Lambs 1 g/10 kg body 
weightday 
35 days Weights increased 9.7% higher than control group 
TG and TC levels were significantly reduced at day 17 (P<0.05) 
HDL levels were not reported 
Urea was not significantly changed at day 35 
El-Sabagh et al., 
2014 
Rabbits 0.5 g/day 60 days Weights increased 3.6% higher than control group 
Only TC levels denoted significant decreases (P<0.05) 
HDL levels showed significant increases with P<0.05 
Kidney status was not reported 
Colla et al., 2008 
Rats 48.03 g/100 g 10 days 8.5% body weight increase recorded 
TC and LDL+VLDL levels were significantly decreased (P<0.05) 
HDL levels were significantly increased (P<0.05) 
Kidney status was not reported 
Nagaoka et al., 
2005 
Calves 25 g/day 57 days 104% weights gain higher than control group 
TC and LDL levels were significantly decreased (P<0.05) 
HDL levels induced (P<0.05) 
BUN levels slightly similar to the control levels 
Heidarpour et al., 
2011 
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Both single and double doses of S. platensis LUQS1 
(CA and CAA groups) demonstrated the better 
enhancement in HDL levels compared to SD and CD 
groups. The highest level for HDL was recorded at day 30 
in the CA group with about 68% higher than the SD group. 
A comparison of the effect of S. platensis on different 
animals was summarized in Table 5.0. Based on the 
results, S. platensis provided several beneficial 
advantages on animals mostly in their weight performance 
and also serum lipids elevation. Besides, the kidney of a 
few of the tested animals remained healthy and 
unaffected. The pre-clinical tests have proven that the 
positive effects of this cyanobacterium occur at an 
extensive range of animals’ species. 
The animals employed in this study were adult and 
healthy domestic cats. Their diets were mixed with 
cholesterol in order to achieve a hyperlipidemic condition. 
Atherosclerosis is one of the hyperlipidemic events which 
could occur in human and animal. However, cats, rats, 
mice, pigs, cows, horses and dogs are among animals 
with atherosclerosis resistance owing to their low CETP 
level (Guyard-Dangremont et al., 1998). CETP is 
responsible to assist the transport of cholesterol and 
triglycerides between the lipoproteins. Lacking in CETP 
resulted in more cholesterol to be transported as HDL. 
Report by Manning and Clarkson (1970) was not 
proportional to the statement as there was atherosclerosis 
event detected in cats. Based on their study, 
atherosclerosis has successfully developed in the 
abdominal aorta and coronary artery. They have induced 
the serum cholesterol levels using a diet rich in lard at 
concentrations of 0.5% (for 8 months) and 2% (for 4 
months). Thus, understanding the basic lipoprotein 
metabolism is imperative since many diseases could 
amend this process due to the elevation levels in plasma 
lipid (Johnson, 2005). In this experiment, the application of 
higher cholesterol percentage specifically (9% cholesterol 
per body weight) has effectively elevated the serum lipids 
in domestic F. catus after 45 days of the study period. 
These outcomes were aligned with Ginzinger et al. (1997) 
where the application of 30% fat and 3% cholesterol 
showed significant changes in serum lipids, providing the 
basis evaluation for susceptibility of New Zealand 
lipoprotein lipase-deficient cats to diet-induced 
atherosclerosis (Ginzinger et al., 1999).  
Previous studies have reported the valuable 
therapeutic functions of Spirulina sp. as anti-cholesterol, 
anti-inflammatory, anti-pyretic, antibacterial and 
anticancer agent (Ozdemir et al., 2004; Kim and Kim, 
2005; El-Sabagh et al., 2014; Konícková et al., 2014; 
Muhammad Nazrul et al., 2014). Referring to Deng and 
Chow (2010), any agents with antioxidant and anti-
inflammatory activities own a tremendous potential for 
combating CVDs. Commonly, antioxidant properties could 
lessen the oxidation of lipids and proteins that indirectly 
defend the body from arterial stiffening and 
atherosclerosis (Carty et al., 2000; Carpenter et al., 2003; 
Ellingsen et al., 2009). In Spirulina sp., phycocyanin, β-
carotene and γ-linolenic acid are among super 
antioxidants which have been recognized affecting the 
CDVs by numbers of researchers (Nagaoka et al., 2005; 
Colla et al., 2008; Deng and Chow, 2010). Scavenging 
free radicals, reducing nitrite production and inhibiting liver 
microsomal lipid peroxidation are among phycocyanin’s 
abilities (Remirez et al., 2002; Romay et al., 2003; Khan et 
al., 2006; Cherng et al., 2007; Riss et al., 2007). β-
carotene involves in lipid peroxidation (Schafer et al., 
2002) while γ-linolenic acid, a precursor to body’s 
prostaglandin, engages with cholesterol synthesis (Krone 
et al., 1988). 
A few accessible reports regarding cats were 
commonly on renal failure (Deguchi and Akuzawa, 1997), 
hypertension (Chetboul et al., 2003), obesity (German, 
2006) and lipid-related study (Ginzinger et al., 1999; Datz 
et al., 2009). Based on this recent data, a tremendous 
potential in treating lipid-related events in F. catus using 
natural cyanobacterium was discovered. It can be a new  
promising and cheaper source to be supplemented in the 




Studies assessing the efficacy of Spirulina sp. and clinical 
practice in F. catus are constrained. In this experiment, S. 
platensis LUQS1 (CA and CAA groups) has effectively 
reduced the TC, TG and LDL levels in cats-fed high 
cholesterol which simultaneously induced the HDL levels 
without affecting the kidney condition. Thus, this 
cyanobacterium has proven its anti-hyperlipidemic 
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